Literature DB >> 24215896

Cognitive dysfunction in unipolar depression: implications for treatment.

Madhukar H Trivedi1, Tracy L Greer.   

Abstract

OBJECTIVE: The primary objective of this review is to examine the literature assessing abnormalities in neural circuitry and cognition early in the course of major depressive disorder (MDD) and the impact of these features on treatment selection and long-term outcomes. DATA SOURCES: English language and peer-reviewed publications were obtained by PubMed/Medline (www.pubmed.org) searches using combinations of major depressive disorder, major depression, or unipolar depression and "first episode", early, cognition, cognitive, executive function and memory. The terms bipolar and psychosis were excluded from the searches. These searches yielded 409 records. STUDY SELECTION: A total of 12 studies, systematic reviews and meta-analyses were selected that evaluated learning, memory and executive function in individuals with major depressive disorder. Additional publications meeting these criteria were identified from the bibliographies of the 12 selected articles and from the "related citations" section of PubMed.
RESULTS: Difficulty in concentrating and indecisiveness are reported as among the most troubling symptoms by patients with MDD and may limit functional recovery. Cognitive deficits in memory and decision-making are present early in the course of MDD and may be accompanied by structural abnormalities in the hippocampus and prefrontal cortex involved in cognitive functions. Although resolution of cognitive symptoms of depression lags behind recovery from mood symptoms in many patients, preliminary evidence suggests they may improve with antidepressant therapy, but can also persist residually.
CONCLUSIONS: New strategies that target cognitive symptoms of depression in addition to mood symptoms are needed to improve long-term outcomes, particularly functional recovery.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antidepressant treatment; Functional impairment; Major depressive disorder (MDD); Neurocognition

Mesh:

Substances:

Year:  2013        PMID: 24215896     DOI: 10.1016/j.jad.2013.09.012

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  70 in total

1.  Neuroprotective evidence of alpha-lipoic acid and desvenlafaxine on memory deficit in a neuroendocrine model of depression.

Authors:  Caren Nádia Soares de Sousa; Lucas Nascimento Meneses; Germana Silva Vasconcelos; Ingridy da Silva Medeiros; Márcia Calheiros Chaves Silva; Fayçal Mouaffak; Oussama Kebir; Cláudio Manuel Gonçalves da Silva Leite; Manoel Cláudio Azevedo Patrocinio; Danielle Macedo; Silvânia Maria Mendes Vasconcelos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-07       Impact factor: 3.000

2.  Short- and Long-term Cognitive Outcomes in Patients With Major Depression Treated With Electroconvulsive Therapy.

Authors:  Megha M Vasavada; Amber M Leaver; Stephanie Njau; Shantanu H Joshi; Linda Ercoli; Gerhard Hellemann; Katherine L Narr; Randall Espinoza
Journal:  J ECT       Date:  2017-12       Impact factor: 3.635

3.  Excitatory Transmission to the Lateral Habenula Is Critical for Encoding and Retrieval of Spatial Memory.

Authors:  Victor Mathis; Brigitte Cosquer; Martino Avallone; Jean-Christophe Cassel; Lucas Lecourtier
Journal:  Neuropsychopharmacology       Date:  2015-05-14       Impact factor: 7.853

4.  Domain-specific impairment in cognitive control among remitted youth with a history of major depression.

Authors:  Amy T Peters; Rachel H Jacobs; Natania A Crane; Kelly A Ryan; Sara L Weisenbach; Olusola Ajilore; Melissa Lamar; Michelle T Kassel; Laura B Gabriel; Amy E West; Jon-Kar Zubieta; Scott A Langenecker
Journal:  Early Interv Psychiatry       Date:  2015-07-14       Impact factor: 2.732

5.  Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment.

Authors:  Jan Engelmann; Stefanie Wagner; Daniel Wollschläger; Sabine Kaaden; Konrad F Schlicht; Nadine Dreimüller; Dieter F Braus; Marianne B Müller; Oliver Tüscher; Helge Frieling; André Tadić; Klaus Lieb
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-03-30       Impact factor: 5.270

Review 6.  Exploring prefrontal cortex functions in healthy humans by transcranial electrical stimulation.

Authors:  Min-Fang Kuo; Michael A Nitsche
Journal:  Neurosci Bull       Date:  2015-02-14       Impact factor: 5.203

7.  Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson's Disease.

Authors:  Sarah M Szymkowicz; Vonetta M Dotson; Jacob D Jones; Michael S Okun; Dawn Bowers
Journal:  J Int Neuropsychol Soc       Date:  2017-10-16       Impact factor: 2.892

8.  Unpacking Major Depressive Disorder: From Classification to Treatment Selection.

Authors:  Sidney H Kennedy; Amanda K Ceniti
Journal:  Can J Psychiatry       Date:  2017-12-26       Impact factor: 4.356

9.  Five Factor Model Personality Traits and Subjective Cognitive Failures.

Authors:  Angelina R Sutin; Damaris Aschwanden; Yannick Stephan; Antonio Terracciano
Journal:  Pers Individ Dif       Date:  2019-12-09

Review 10.  Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model.

Authors:  Amanda R Mathew; Lee Hogarth; Adam M Leventhal; Jessica W Cook; Brian Hitsman
Journal:  Addiction       Date:  2016-10-26       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.